Terry Furlong

Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

Christopher G. Kanakry, Paul V. O’Donnell, Terry Furlong et al. · Journal of Clinical Oncology · 2014 · 280 citations · Full text

Medicine, Hematology, Immunology +17

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation

Marco Mielcarek, Terry Furlong, Paul V. O’Donnell et al. · Blood · 2016 · 228 citations · Full text

Life Sciences, Hematology, Immunology +16

SIROLIMUS (RAPAMYCIN) FOR THE TREATMENT OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE1

Ana Benito, Terry Furlong, Paul J. Martin et al. · Transplantation · 2001 · 182 citations

Life Sciences, Immunology, Pharmacotherapy +11

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes

Marco Mielcarek, Barry E. Storer, Michael Boeckh et al. · Blood · 2008 · 137 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

A Phase I/II Study of Mycophenolate Mofetil in Combination with Cyclosporine for Prophylaxis of Acute Graft-versus-Host Disease after Myeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation

Richard A. Nash, Laura Johnston, Pablo Parker et al. · Biology of Blood and Marrow Transplantation · 2005 · 124 citations

Pharmacy, Pharmacology, Pharmacotherapy +14